News Conference News CRT 2021 BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients Caitlin E. Cox March 16, 2021
News Daily News EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case Yael L. Maxwell March 03, 2021
News Industry News MagicTouch SCB Granted 'Breakthrough Device Designation' for the treatment of Small Coronary Artery Lesions. December 16, 2020
News Conference News ‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III Shelley Wood November 19, 2020
News Conference News TCT 2020 OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES L.A. McKeown October 17, 2020
Presentation TCT 2020 OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier Presenter: Dean J. Kereiakes October 17, 2020
News Conference News TCT 2020 Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI Todd Neale October 14, 2020
Presentation TCT 2020 TCT 529: 12-y/o Female Patient Treated With a Second-Generation Tyrocore Sirolimus-Eluting Bioresorbable Scaffold in a Denovo Coronary Stenosis in the Donor Heart After Transplantation Presenter: Matthias Lutz October 14, 2020
Presentation TCT 2020 TCT 238: One Year Clinical Outcomes of Ultrathin Biodegradable Polymer Coated Sirolimus Eluting Stents in Total Occlusion: A Multicentre, All-Comer Analysis Presenter: Prakash Ajmera October 14, 2020
Presentation TCT 2020 TCT 390: Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study Presenter: Martin Hudec October 14, 2020
Presentation TCT 2020 TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population Presenter: Luca Testa October 14, 2020
Presentation TCT 2020 TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions Presenter: Alexandre Abizaid October 14, 2020
Presentation TCT 2020 TCT 252: Use of Sirolimus-Coated Balloon in De Novo Small Vessel Coronary Lesions; Long-Term Follow-Up From a Single Centre Registry Presenter: A D S P K Athukorala October 14, 2020
Presentation TCT 2020 TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease Presenter: Markus Krackhardt October 14, 2020
Presentation TCT 2020 TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results Presenter: Bernhard Witzenbichler October 14, 2020
Presentation TCT 2020 TCT 255: Long Term Outcome After Coronary Revascularization With Sirolimus Coated Balloon in Patients With Small Vessel Disease (≤2.75mm): 3-Years Results From Nanolute Real-World Study Presenter: Bernardo Cortese October 14, 2020
Presentation TCT 2020 TCT 273: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 12 Month Outcomes – FANTOM STEMI Pilot Study Presenter: Lukasz Koltowski October 14, 2020
Presentation TCT 2020 TCT 275: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – First Report: 1 Year Outcomes Presenter: Matthias Lutz October 14, 2020
News Industry News Concept Medical announces enrolment of index patient in the crucial Transform -1 RCT using MagicTouch sirolimus coated balloon for small coronary vessels September 02, 2020
News Daily News Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5 Michael O'Riordan July 07, 2020